Find Migalastat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Migalastat hcl, 75172-81-5, Deoxygalactonojirimycin hydrochloride, Galafold, 1-deoxygalactonojirimycin hydrochloride, Amigal
Molecular Formula
C6H14ClNO4
Molecular Weight
199.63  g/mol
InChI Key
ZJIHMALTJRDNQI-OLALXQGDSA-N
FDA UNII
CLY7M0XD20

Migalastat
1 2D Structure

Migalastat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol;hydrochloride
2.1.2 InChI
InChI=1S/C6H13NO4.ClH/c8-2-3-5(10)6(11)4(9)1-7-3;/h3-11H,1-2H2;1H/t3-,4+,5+,6-;/m1./s1
2.1.3 InChI Key
ZJIHMALTJRDNQI-OLALXQGDSA-N
2.1.4 Canonical SMILES
C1C(C(C(C(N1)CO)O)O)O.Cl
2.1.5 Isomeric SMILES
C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O.Cl
2.2 Other Identifiers
2.2.1 UNII
CLY7M0XD20
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-butyl-2-(hydroxylmethyl)piperidine-3,4,5-triol

2. 1-deoxy-galactonojirimycin

3. 1-deoxygalacto-nojirimycin

4. 1-deoxygalactonojirimycin

5. At1001 Deoxyjirimycin

6. Galafold

7. Gr181413a

8. Lucerastat

9. Migalastat

10. Migalastat Hcl

11. N-butyldeoxygalacto-nojirimycin

12. N-butyldeoxygalactonojirimycin

13. Nb-dgj

2.3.2 Depositor-Supplied Synonyms

1. Migalastat Hcl

2. 75172-81-5

3. Deoxygalactonojirimycin Hydrochloride

4. Galafold

5. 1-deoxygalactonojirimycin Hydrochloride

6. Amigal

7. Migalastat Hydrochloride [usan]

8. Migalastat (hydrochloride)

9. Cly7m0xd20

10. 75172-81-5 (hcl)

11. At-1001 (migalastat Hydrochloride)

12. (2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol Hydrochloride

13. (2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol Hydrochloride.

14. Gr181413a

15. Unii-cly7m0xd20

16. Migalastathcl

17. Galafold (tn)

18. Deoxygalactonojirimycin,hydrochloride

19. Deoxygalactonojirimycin, Hydrochloride

20. 1-deoxygalactonojirimycin Hcl

21. Schembl3802618

22. Chembl2107355

23. Dtxsid801026249

24. (+)-migalastat Hydrochloride

25. Hy-14929a

26. Mfcd00269962

27. Migalastat Hydrochloride (jan/usan)

28. Migalastat Hydrochloride [mi]

29. Migalastat Hydrochloride [jan]

30. 3,4,5-piperidinetriol, 2-(hydroxymethyl)-, Hydrochloride, (2r,3s,4r,5s)-

31. At13690

32. Cs-6380

33. Migalastat Hydrochloride [who-dd]

34. Migalastat Hydrochloride [orange Book]

35. D05031

36. 1,5-dideoxy-1,5-imino-d-galactitol Hydrochloride

37. W-203722

38. Q27275527

39. (+)-(2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol Hydrochloride

40. (2r,3s,4r,5s)-2-(hydroxymethyl)-3,4,5-piperidinetriol Hydrochloride

41. (2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol;hydrochloride

42. 3,4,5-piperidinetriol, 2-(hydroxymethyl)-, Hydrochloride (1:1), (2r,3s,4r,5s)-

43. 3,4,5-piperidinetriol, 2-(hydroxymethyl)-, Hydrochloride,[2r-(2a,3a,4a,5b)]-

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 199.63 g/mol
Molecular Formula C6H14ClNO4
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count5
Rotatable Bond Count1
Exact Mass199.0611356 g/mol
Monoisotopic Mass199.0611356 g/mol
Topological Polar Surface Area93 Ų
Heavy Atom Count12
Formal Charge0
Complexity132
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Galafold is indicated for long-term treatment of adults and adolescents aged 16 years and older with a confirmed diagnosis of Fabry disease (-galactosidase A deficiency) and who have an amenable mutation.


5 Pharmacology and Biochemistry
5.1 ATC Code

A16AX


USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 37632

Submission : 2023-02-26

Status : Active

Type : II

Metrochem

02

Cancer Research
Not Confirmed

02

Cancer Research
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2022-04-08

Pay. Date : 2022-02-25

DMF Number : 36827

Submission : 2022-02-25

Status : Active

Type : II

blank

03

Cancer Research
Not Confirmed

03

Cancer Research
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2022-06-09

Pay. Date : 2022-05-26

DMF Number : 36729

Submission : 2022-03-31

Status : Active

Type : II

blank

04

Cancer Research
Not Confirmed

05

Cancer Research
Not Confirmed

05

Cancer Research
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2022-03-17

Pay. Date : 2021-12-15

DMF Number : 36618

Submission : 2022-02-28

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

Migalastat Hydrochloride IH

Date of Issue : 2022-06-03

Valid Till : 2025-05-25

Written Confirmation Number : WC-0002A3

Address of the Firm : A-2, A-2/1, A-2/2, UPSIDC Industrial Area, Bijnor Road, Gajraula

TAPI Company Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Migalastat

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

Migalastat

About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...

Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, driving progress in the pharmaceutical industry. Leveraging our extensive experience and world-class expertise, we deliver one of the most comprehensive API portfolios in the industry with over 350 Products portfolio. Additionally, we provide tailored CDMO services, harnessing our proficiency in diverse technologies to meet our partners' unique needs, ensuring flexibility and excellence in every project.
TAPI Company Banner

03

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Migalastat

About the Company : Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company comme...

Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
blank

04

Hetero Drugs

India
Immuno-Oncology 360
Not Confirmed
arrow

Hetero Drugs

India
arrow
Immuno-Oncology 360
Not Confirmed

Migalastat

About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs. Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.
blank

05

Lupin Ltd

India
Immuno-Oncology 360
Not Confirmed
arrow

Lupin Ltd

India
arrow
Immuno-Oncology 360
Not Confirmed

Migalastat

About the Company : Lupin Limited is a global pharmaceutical leader, based in Mumbai, India, with a strong presence in over 100 markets. It specializes in branded and generic formulations, complex gen...

Lupin Limited is a global pharmaceutical leader, based in Mumbai, India, with a strong presence in over 100 markets. It specializes in branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Known for its innovations, Lupin excels in therapeutic areas such as respiratory, cardiovascular, anti-diabetic, and more. With 15 advanced manufacturing facilities and 7 research centers worldwide, Lupin is driven by a dedicated workforce of over 22,000 professionals.
blank

06

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Migalastat Hydrochloride

About the Company : Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API e...

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.
blank

07

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Migalastat

About the Company : Founded in 2010, Ausun Pharmaceutical is a public company, specialized in high-tech. threshold Generic API Dev. & providing CDMO services. Ausun owns & operates 1 on-site R&D Cente...

Founded in 2010, Ausun Pharmaceutical is a public company, specialized in high-tech. threshold Generic API Dev. & providing CDMO services. Ausun owns & operates 1 on-site R&D Center & 1 Mfg. Site which has been certified by US FDA, JPMDA & EMA, supported by >550 highly trained professionals across departments & >200 scientists to bring high quality products to customers. More than 130 products/projects have been successfully developed since founded. Process Innovation, R&D Efficiency & Cost Effectiveness are Ausun's key competencies. Create Chemistry and to be the 1st Class Worldwide Pharmaceutical Corporation is our goal.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"MIGALASTAT HYDROCHLORIDE","year":"2021","qtr":"Q2","strtotime":1617215400,"product":"MIGALASTAT HYDROCHLORIDE - CONTROL BATCH","address":"M-34, SAKET,","city":"NEW DELHI.","supplier":"TAPI TECHNOLOGY & API SERVICES","supplierCountry":"INDIA","foreign_port":"TEL AVIV YAFO","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"ISRAEL","quantity":"7.00","actualQuantity":"7","unit":"KGS","unitRateFc":"8297","totalValueFC":"55380.1","currency":"USD","unitRateINR":589000,"date":"01-Apr-2021","totalValueINR":"4123000","totalValueInUsd":"55380.1","indian_port":"DELHI AIR","hs_no":"29333990","bill_no":"9826099","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"M-34, SAKET,, NEW DELHI.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"MIGALASTAT HYDROCHLORIDE","year":"2021","qtr":"Q2","strtotime":1621967400,"product":"MIGALASTAT HYDROCHLORIDE - CONTROL BATCH","address":"M-34, SAKET,","city":"NEW DELHI.","supplier":"TAPI TECHNOLOGY & API SERVICES","supplierCountry":"INDIA","foreign_port":"TEL AVIV YAFO","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"ISRAEL","quantity":"8.13","actualQuantity":"8.13","unit":"KGS","unitRateFc":"8297","totalValueFC":"66075.7","currency":"USD","unitRateINR":595325.95325953257,"date":"26-May-2021","totalValueINR":"4840000","totalValueInUsd":"66075.7","indian_port":"DELHI AIR","hs_no":"29333990","bill_no":"2000931","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"M-34, SAKET,, NEW DELHI.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1626892200,"product":"MIGALASTAT HYDROCHLORIDE-CONTROL BATCH N O 1918000821 MFG DT JUNE 2021 RETEST DT DECEMBER 2021.","address":"M-34, SAKET,","city":"NEW DELHI.","supplier":"TAPI TECHNOLOGY & API SERVICES","supplierCountry":"INDIA","foreign_port":"TEL AVIV YAFO","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"ISRAEL","quantity":"6.92","actualQuantity":"6.92","unit":"KGS","unitRateFc":"8449.2","totalValueFC":"56525.1","currency":"USD","unitRateINR":608761.53757225431,"date":"22-Jul-2021","totalValueINR":"4212629.84","totalValueInUsd":"56525.1","indian_port":"DELHI AIR","hs_no":"29333990","bill_no":"3314525","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"M-34, SAKET,, NEW DELHI.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1628447400,"product":"MIGALASTAT HYDROCHLORIDE-CONTROL BATCH N O 1918000421 MFG DT APRIL 2021 RETEST D T OCTOBER 2021.","address":"M-34, SAKET,","city":"NEW DELHI.","supplier":"TAPI TECHNOLOGY & API SERVICES","supplierCountry":"INDIA","foreign_port":"TEL AVIV YAFO","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"ISRAEL","quantity":"9.07","actualQuantity":"9.07","unit":"KGS","unitRateFc":"8415","totalValueFC":"74145.1","currency":"USD","unitRateINR":606301.61962513789,"date":"09-Aug-2021","totalValueINR":"5499155.69","totalValueInUsd":"74145.1","indian_port":"DELHI AIR","hs_no":"29333990","bill_no":"3720593","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"M-34, SAKET,, NEW DELHI.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1628447400,"product":"MIGALASTAT HYDROCHLORIDE-CONTROL BATCH N O.1918000821 MFG DT JUNE 2021 RETEST DT DECEMBER 2021.","address":"M-34, SAKET,","city":"NEW DELHI.","supplier":"TAPI TECHNOLOGY & API SERVICES","supplierCountry":"INDIA","foreign_port":"TEL AVIV YAFO","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"ISRAEL","quantity":"6.92","actualQuantity":"6.92","unit":"KGS","unitRateFc":"8415","totalValueFC":"56569.4","currency":"USD","unitRateINR":606301.56791907514,"date":"09-Aug-2021","totalValueINR":"4195606.85","totalValueInUsd":"56569.4","indian_port":"DELHI AIR","hs_no":"29333990","bill_no":"3720593","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"M-34, SAKET,, NEW DELHI.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672252200,"product":"OTHER ORGANIC COMPOUNDS-MIGALASTAT HYDRO","address":"SETHNA BUILDING 4TH FLOOR 55,MAHAR SHI KARVE ROAD MARINE LINE","city":"MUMBAI,MAHARASHTRA","supplier":"MEGAFINE PHARMA (P) LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"TO THE ORDER OF","customerCountry":"ARGENTINA","quantity":"1.00","actualQuantity":"1000","unit":"GMS","unitRateFc":"73","totalValueFC":"72276.1","currency":"USD","unitRateINR":5956,"date":"29-Dec-2022","totalValueINR":"5956000","totalValueInUsd":"72276.1","indian_port":"BOMBAY AIR","hs_no":"29333990","bill_no":"6525950","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"SETHNA BUILDING 4TH FLOOR 55,MAHAR SHI KARVE ROAD MARINE LINE, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692556200,"product":"MIGALASTAT HYDROCHLORIDE","address":"MSN HOUSE PLOT NO. C-24INDUSTRI AL ESTATE SANATH NAGAR","city":"Hyderabad","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"NA","customer":"TO THE ORDER OF","customerCountry":"UNITED ARAB EMIRATES","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"69099.8","totalValueFC":"68569","currency":"USD","unitRateINR":5680000.0250000004,"date":"21-Aug-2023","totalValueINR":"5680000.025","totalValueInUsd":"68569","indian_port":"HYDERABAD ICD","hs_no":"29333200","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD ICD","supplierAddress":"MSN HOUSE PLOT NO. C-24INDUSTRI AL ESTATE SANATH NAGAR, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1707244200,"product":"ACTIVE PHARMACEUTICAL INGREDIENTS - OTHER ORGANIC COMPOUNDS - MIGALASTAT HYDROCHLORIDE IHS","address":"SETHNA BUILDING, 4TH FLR,","city":"LINES, MUMBAI ,MAHARASHTRA","supplier":"MEGAFINE PHARMA (P) LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"TO THE ORDER OF,","customerCountry":"ARGENTINA","quantity":"0.08","actualQuantity":"75","unit":"GMS","unitRateFc":"140","totalValueFC":"10296.7","currency":"USD","unitRateINR":11391.397866666666,"date":"07-Feb-2024","totalValueINR":"854354.84","totalValueInUsd":"10296.7","indian_port":"Bombay Air","hs_no":"29333990","bill_no":"7354011","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"SETHNA BUILDING, 4TH FLR,, LINES, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732127400,"product":"MIGALASTAT HYDROCHLORIDE","address":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower","city":"Hyderabad","supplier":"APITORIA PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"REYKJAVIK KEFLAVIK","customer":"CORIPHARMA EHF","customerCountry":"ICELAND","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"27500","totalValueFC":"2525.3","currency":"USD","unitRateINR":2131044.7999999998,"date":"21-Nov-2024","totalValueINR":"213104.48","totalValueInUsd":"2525.3","indian_port":"Hyderabad Air","hs_no":"29333200","bill_no":"5784874","productDescription":"API","marketType":"REGULATED MARKET","country":"ICELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733941800,"product":"MIGALASTAT HYDROCHLORIDE","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"GULF AGENCY COMPANY DUBAI LLC","customerCountry":"UNITED ARAB EMIRATES","quantity":"0.02","actualQuantity":"0.02","unit":"KGS","unitRateFc":"69300","totalValueFC":"1304.7","currency":"USD","unitRateINR":5542970,"date":"12-Dec-2024","totalValueINR":"110859.4","totalValueInUsd":"1304.7","indian_port":"Hyderabad Air","hs_no":"29333200","bill_no":"6395442","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""}]
01-Apr-2021
12-Dec-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

FDF Dossiers

read-more
read-more

01

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

MIGALASTAT HYDROCHLORIDE

Brand Name : GALAFOLD

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 123MG BASE

Packaging :

Approval Date : 2018-08-10

Application Number : 208623

Regulatory Info : RX

Registration Country : USA

blank

02

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Migalastatum

Brand Name : Galafold

Dosage Form : Kaps

Dosage Strength : 123mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Country
Immuno-Oncology 360
Not Confirmed
arrow

Country
arrow
Immuno-Oncology 360
Not Confirmed

MIGALASTAT (MIGALASTAT HYDROCHLORIDE)

Brand Name : GALAFOLD

Dosage Form : CAPSULE

Dosage Strength : 123MG

Packaging : 14

Approval Date :

Application Number : 2468042

Regulatory Info :

Registration Country : Canada

blank

04

Country
Immuno-Oncology 360
Not Confirmed
arrow

Country
arrow
Immuno-Oncology 360
Not Confirmed

migalastat

Brand Name : Galafold

Dosage Form :

Dosage Strength :

Packaging : 14

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Migalastatum

Brand Name : Galafold

Dosage Form : Kaps

Dosage Strength : 123mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 75172-81-5 / Migalastat API manufacturers, exporters & distributors?

Migalastat manufacturers, exporters & distributors 1

22

PharmaCompass offers a list of Migalastat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Migalastat manufacturer or Migalastat supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Migalastat manufacturer or Migalastat supplier.

PharmaCompass also assists you with knowing the Migalastat API Price utilized in the formulation of products. Migalastat API Price is not always fixed or binding as the Migalastat Price is obtained through a variety of data sources. The Migalastat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Migalastat

Synonyms

Migalastat hcl, 75172-81-5, Deoxygalactonojirimycin hydrochloride, Galafold, 1-deoxygalactonojirimycin hydrochloride, Amigal

Cas Number

75172-81-5

Unique Ingredient Identifier (UNII)

CLY7M0XD20

Migalastat Hydrochloride Manufacturers

A Migalastat Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Migalastat Hydrochloride, including repackagers and relabelers. The FDA regulates Migalastat Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Migalastat Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Migalastat Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Migalastat Hydrochloride Suppliers

A Migalastat Hydrochloride supplier is an individual or a company that provides Migalastat Hydrochloride active pharmaceutical ingredient (API) or Migalastat Hydrochloride finished formulations upon request. The Migalastat Hydrochloride suppliers may include Migalastat Hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Migalastat Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Migalastat Hydrochloride USDMF

A Migalastat Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Migalastat Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Migalastat Hydrochloride DMFs exist exist since differing nations have different regulations, such as Migalastat Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Migalastat Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Migalastat Hydrochloride USDMF includes data on Migalastat Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Migalastat Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Migalastat Hydrochloride suppliers with USDMF on PharmaCompass.

Migalastat Hydrochloride KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Migalastat Hydrochloride Drug Master File in Korea (Migalastat Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Migalastat Hydrochloride. The MFDS reviews the Migalastat Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Migalastat Hydrochloride KDMF to evaluate the safety and efficacy of the drug.

After submitting a Migalastat Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Migalastat Hydrochloride API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Migalastat Hydrochloride suppliers with KDMF on PharmaCompass.

Migalastat Hydrochloride WC

A Migalastat Hydrochloride written confirmation (Migalastat Hydrochloride WC) is an official document issued by a regulatory agency to a Migalastat Hydrochloride manufacturer, verifying that the manufacturing facility of a Migalastat Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Migalastat Hydrochloride APIs or Migalastat Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Migalastat Hydrochloride WC (written confirmation) as part of the regulatory process.

click here to find a list of Migalastat Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.

Migalastat Hydrochloride NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Migalastat Hydrochloride as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Migalastat Hydrochloride API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Migalastat Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Migalastat Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Migalastat Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Migalastat Hydrochloride suppliers with NDC on PharmaCompass.

Migalastat Hydrochloride GMP

Migalastat Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Migalastat Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Migalastat Hydrochloride GMP manufacturer or Migalastat Hydrochloride GMP API supplier for your needs.

Migalastat Hydrochloride CoA

A Migalastat Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Migalastat Hydrochloride's compliance with Migalastat Hydrochloride specifications and serves as a tool for batch-level quality control.

Migalastat Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Migalastat Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Migalastat Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Migalastat Hydrochloride EP), Migalastat Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Migalastat Hydrochloride USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty